Clinical trial
An Open Study of Foscarnet Treatment of Acyclovir-Resistant Herpes Simplex Virus…
NCT00002021 · Astra USA, Industry · Completed
Key facts
| NCT number | NCT00002021 |
|---|---|
| Title | An Open Study of Foscarnet Treatment of Acyclovir-Resistant Herpes Simplex Virus in Patients With the Acquired Immunodeficiency Syndrome and Other Immunodeficiencies |
| Official title | An Open Study of Foscarnet Treatment of Acyclovir-Resistant Herpes Simplex Virus in Patients With the Acquired Immunodeficiency Syndrome and Other Immunodeficiencies |
| Lead sponsor | Astra USA, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Herpes Simplex, HIV Infections |
| Intervention type | Drug |
| Interventions | Foscarnet sodium |
| First posted | Aug 31, 2001 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: